[A model code of practice in accordance with the Dutch Embryo act]

Area of Science:

• Reproductive Medicine
• Bioethics
• Healthcare Regulation

Context:

• In vitro fertilisation (IVF) procedures in the Netherlands are governed by the Dutch Embryo Act.
• Institutions must adhere to legally prescribed protocols and specific standards for clinical and laboratory aspects.
• A model protocol exists to guide institutions, allowing for local adaptations.

Purpose:

• To outline the regulatory framework and procedural guidelines for IVF and related treatments in the Netherlands.
• To detail requirements for licensed fertility centers, personnel, and patient management.
• To clarify regulations concerning embryo selection, cryopreservation, and oocyte donation.

Summary:

• IVF centers must meet stringent standards; ovarian stimulation decisions require careful patient assessment, balancing benefits against risks like OHSS.
• Embryo cryopreservation contracts necessitate mutual agreement on usage, with the right for parties to withdraw consent.
• Oocyte donation is primarily for premature ovarian failure, with age limits for acceptors (45) and donors (min 18, recommended caution under 30, max 40 for efficacy).
• Medical-ethical committee approval is mandatory for oocyte donation, often supported by gynaecologist and psychosocial reports.
• Hospital-based delivery is advised post-oocyte donation due to elevated pregnancy complication risks.
• Post-mortem gamete or embryo use is permissible with prior written consent.

Impact:

• Ensures standardized, ethical, and safe practices in assisted reproductive technologies.
• Provides a clear legal and procedural framework for fertility treatments and embryo management.
• Upholds patient rights and ethical considerations in gamete and embryo donation and storage.